WebAtagi S, Kawahara M, Yokoyama A, et al. Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology … Webjcog0301:「高齢者切除不能局所進行型非小細胞肺がんに対する 胸部放射線単独と低用量連日カルボプラチン+胸部放射線同時併用療法との ランダム化比較試験」 [ 2012年4 …
Phase I study of weekly nab-paclitaxel plus carboplatin and
Web30 lug 2024 · 1 INTRODUCTION. Lung cancer is one of the most frequently diagnosed cancers with a high rate of cancer-related deaths. 1 About 30% of patients with non-small cell lung cancer (NSCLC) present with Stage III disease, of which less than a third survive for longer than 5 years. 2 Concurrent chemoradiotherapy (cCRT) with a curative intent is … Web8 set 2024 · In Japan, based on a randomized controlled trial conducted by the Japan Clinical Oncology Group (JCOG0301), low-dose carboplatin and concurrent thoracic radiotherapy are the standard treatment for elderly patients with unresectable locally advanced NSCLC . choobee.com.my
Management of stage III non-small cell lung cancer - UpToDate
Web22 ago 2005 · Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the … Web1 set 2024 · The JCOG0301 trial was a multicenter, phase III randomized trial evaluating thoracic RT alone versus RT in combination with concurrent daily low-dose carboplatin in elderly patients with unresectable locally advanced NSCLC. The study was conducted as previously described. 3 Briefly, ... Web17 mar 2024 · In Japan, a randomized controlled trial conducted by the Japan Clinical Oncology Group (JCOG0301) demonstrated the superiority of daily low-dose carboplatin … grease in gear box